GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuPharma PLC (AQSE:IMM.GB) » Definitions » Deferred Policy Acquisition Costs

ImmuPharma (AQSE:IMM.GB) Deferred Policy Acquisition Costs


View and export this data going back to 2016. Start your Free Trial

What is ImmuPharma Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


ImmuPharma Business Description

Industry
Traded in Other Exchanges
Address
One Bartholomew Close, London, GBR, EC1A 7BL
ImmuPharma PLC is a drug discovery and development company. The pipeline of the company includes novel peptide-based therapeutics within two therapy areas: autoimmunity & inflammation and anti-infectives. The company's drug candidate is Lupuzor, which treats lupus, a life-threatening autoimmune disease, and other candidates are P140 CIDP and BioAMB Fungal infections.